GASTROINTESTINAL CANCER PROGRAMThe Gastrointestinal (Gl) Cancer Program was one of the original programs in Jefferson's Kimmel CancerCenter. It comprises sixteen cancer center faculty who represent eight departments within the School ofMedicine (Anatomy, Cell Biology, and Pathology; Cancer Biology; Family Medicine; Internal Medicine;Medical Oncology; Radiology; and Pharmacology And Experimental Therapeutics; Surgery;) and theChristiana Care Health System (Helen F. Graham Cancer Center). Faculty hold appointments in fivegraduate programs in the School of Medicine (Cell Biology; Biochemistry; Genetics; Immunology; MolecularPharmacology). Their work is supported by 4.4 million in peer-reviewed funding (3.7 million from NCI). In thelast funding period, program members had 401 publications of which 5% are intra-programmmatic and 17%are inter-programmatic. The overarching goal of this multidisciplinary program is to define the fundamentalmechanisms underlying Gl malignancies so that they may be translated into diagnostic and therapeuticinnovations in managing cancer in patients and populations. Program members pursue parallel effortsorganized vertically along organ-based disease processes and horizontally from discovery throughtranslation and clinical development, to application. Members employ common and collaborativeexperimental paradigms with the goals of (1) defining previously unappreciated molecular, genetic, andepigenetic mechanisms underlying organ-based tumorigenesis, (2) translating defined mechanism-basedcomponents into novel in vitro and in vivo diagnostic tools that will enable early detection, prognosis,prediction, risk-stratification, and prevention in Gl malignancies, (3) exploiting novel mechanisms to definemolecularly targeted therapeutic approaches for cancer prevention, treatment, and control, (4) advancingnovel discoveries from program member laboratories into development as clinical trials, and (5) ultimatelyadvancing diagnostic and therapeutic modalities which have been successful in clinical development intoevidence-based practice for cancer prevention and control across populations. Members are interactive andcohesive. Under the direction of the program leader and co-leader, members coordinate planning, newresearch directions, and interactions with other research programs in the cancer center. Over the past 6years, the faculty have gained momentum and built their reputation, reflecting remarkable innovation indisease diagnosis and management.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-09
Application #
7712909
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-05
Project End
2013-05-31
Budget Start
2008-09-05
Budget End
2009-05-31
Support Year
9
Fiscal Year
2008
Total Cost
$20,798
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications